hESC-derived retinal pigment epithelium cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for hESC-derived retinal pigment epithelium cells, covering 2024-10-31 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD